Journal article
Methicillin-resistant Staphylococcus aureus, Western Australia
Emerging Infectious Diseases, Vol.11(10), pp.1584-1590
2005
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a notable cause of hospital-acquired infections. A statewide screening and control policy was implemented in Western Australia (WA) after an outbreak of epidemic MRSA in a Perth hospital in 1982. We report on statutory notifications from1998 to 2002 and review the 20-year period from 1983 to 2002. The rate of reporting of community-associated Western Australia MRSA (WAMRSA) escalated from 1998 to 2002 but may have peaked in 2001. Several outbreaks were halted, but they resulted in an increase in reports as a result of screening. A notable increase in ciprofloxacin resistance during the study period was observed as a result of more United Kingdom epidemic MRSA (EMRSA) -15 and -16. WA has seen a persistently low incidence of multidrug-resistant MRSA because of the screening and decolonization program. Non–multidrug-resistant, community-associated WAMRSA strains have not established in WA hospitals.
Details
- Title
- Methicillin-resistant Staphylococcus aureus, Western Australia
- Authors/Creators
- L. Dailey (Author/Creator)G.W. Coombs (Author/Creator)F.G. O'Brien (Author/Creator)J.W. Pearman (Author/Creator)K. Christiansen (Author/Creator)W.B. Grubb (Author/Creator)T.V. Riley (Author/Creator)
- Publication Details
- Emerging Infectious Diseases, Vol.11(10), pp.1584-1590
- Publisher
- National Center for Infectious Diseases
- Identifiers
- 991005543314307891
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
125 File views/ downloads
69 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.23 Antibiotics & Antimicrobials
- 1.23.173 MRSA and VRE
- Web Of Science research areas
- Immunology
- Infectious Diseases
- ESI research areas
- Immunology